Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.41
IVC's Cash-to-Debt is ranked lower than
80% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. IVC: 0.41 )
Ranked among companies with meaningful Cash-to-Debt only.
IVC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: 1.92
Current: 0.41
0
1.92
Equity-to-Asset 0.40
IVC's Equity-to-Asset is ranked lower than
82% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. IVC: 0.40 )
Ranked among companies with meaningful Equity-to-Asset only.
IVC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.47 Max: 0.61
Current: 0.4
0.26
0.61
Debt-to-Equity 0.55
IVC's Debt-to-Equity is ranked lower than
70% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 0.28 vs. IVC: 0.55 )
Ranked among companies with meaningful Debt-to-Equity only.
IVC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.66 Max: 1.95
Current: 0.55
0.04
1.95
Debt-to-EBITDA -13.49
IVC's Debt-to-EBITDA is ranked lower than
99.99% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. IVC: -13.49 )
Ranked among companies with meaningful Debt-to-EBITDA only.
IVC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -13.49  Med: 3.81 Max: 169.31
Current: -13.49
-13.49
169.31
Piotroski F-Score: 3
Altman Z-Score: 1.93
Beneish M-Score: -2.51
WACC vs ROIC
18.35%
-8.74%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % -4.16
IVC's Operating Margin % is ranked lower than
58% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. IVC: -4.16 )
Ranked among companies with meaningful Operating Margin % only.
IVC' s Operating Margin % Range Over the Past 10 Years
Min: -4.63  Med: 0.17 Max: 4.99
Current: -4.16
-4.63
4.99
Net Margin % -7.92
IVC's Net Margin % is ranked lower than
62% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 1.42 vs. IVC: -7.92 )
Ranked among companies with meaningful Net Margin % only.
IVC' s Net Margin % Range Over the Past 10 Years
Min: -7.92  Med: 0.1 Max: 2.48
Current: -7.92
-7.92
2.48
ROE % -18.10
IVC's ROE % is ranked lower than
65% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.48 vs. IVC: -18.10 )
Ranked among companies with meaningful ROE % only.
IVC' s ROE % Range Over the Past 10 Years
Min: -18.1  Med: 0.26 Max: 6.67
Current: -18.1
-18.1
6.67
ROA % -7.79
IVC's ROA % is ranked lower than
59% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: -0.20 vs. IVC: -7.79 )
Ranked among companies with meaningful ROA % only.
IVC' s ROA % Range Over the Past 10 Years
Min: -7.79  Med: 0.11 Max: 3.08
Current: -7.79
-7.79
3.08
ROC (Joel Greenblatt) % -25.54
IVC's ROC (Joel Greenblatt) % is ranked lower than
62% of the 328 Companies
in the Global Medical Devices industry.

( Industry Median: 3.76 vs. IVC: -25.54 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
IVC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -29.81  Med: 0.92 Max: 23.37
Current: -25.54
-29.81
23.37
3-Year Revenue Growth Rate -8.30
IVC's 3-Year Revenue Growth Rate is ranked lower than
75% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 4.00 vs. IVC: -8.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
IVC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -8.3  Med: 6.85 Max: 18
Current: -8.3
-8.3
18
3-Year EPS without NRI Growth Rate -8.10
IVC's 3-Year EPS without NRI Growth Rate is ranked lower than
61% of the 228 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. IVC: -8.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
IVC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -74.2  Med: 18.9 Max: 239.1
Current: -8.1
-74.2
239.1
GuruFocus has detected 8 Warning Signs with Invacare Corp IVC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» IVC's 30-Y Financials

Financials (Next Earnings Date: 2018-05-08)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

IVC Guru Trades in Q1 2017

Chuck Royce 1,211,712 sh (+11.71%)
Charles Brandes 2,018,749 sh (+5.05%)
Barrow, Hanley, Mewhinney & Strauss 316,036 sh (+3.50%)
Arnold Schneider 127,525 sh (unchged)
Mariko Gordon 2,922,828 sh (-1.69%)
HOTCHKIS & WILEY 1,338,095 sh (-3.42%)
» More
Q2 2017

IVC Guru Trades in Q2 2017

Jim Simons 130,600 sh (New)
Leucadia National 12,204 sh (New)
Arnold Schneider 288,770 sh (+126.44%)
Chuck Royce 1,354,739 sh (+11.80%)
Barrow, Hanley, Mewhinney & Strauss 316,036 sh (unchged)
HOTCHKIS & WILEY 1,330,505 sh (-0.57%)
Mariko Gordon 2,828,630 sh (-3.22%)
Charles Brandes 1,532,394 sh (-24.09%)
» More
Q3 2017

IVC Guru Trades in Q3 2017

Barrow, Hanley, Mewhinney & Strauss 2,383,222 sh (+654.10%)
Jim Simons 268,400 sh (+105.51%)
Chuck Royce 1,414,169 sh (+4.39%)
Leucadia National Sold Out
Arnold Schneider 278,770 sh (-3.46%)
Mariko Gordon 2,576,691 sh (-8.91%)
Charles Brandes 1,276,880 sh (-16.67%)
HOTCHKIS & WILEY 786,865 sh (-40.86%)
» More
Q4 2017

IVC Guru Trades in Q4 2017

Jim Simons 309,100 sh (+15.16%)
Chuck Royce 1,574,733 sh (+11.35%)
HOTCHKIS & WILEY 867,255 sh (+10.22%)
Mariko Gordon 2,566,583 sh (-0.39%)
Barrow, Hanley, Mewhinney & Strauss 2,359,352 sh (-1.00%)
Arnold Schneider 91,468 sh (-67.19%)
Charles Brandes 225,773 sh (-82.32%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2017-12-31 Reduce -0.39%0.01%$13.95 - $17.9 $ 18.3013%2,566,583
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -1.00%$13.95 - $17.9 $ 18.3013%2,359,352
HOTCHKIS & WILEY 2017-12-31 Add 10.22%0.01%$13.95 - $17.9 $ 18.3013%867,255
Charles Brandes 2017-12-31 Reduce -82.32%0.34%$13.95 - $17.9 $ 18.3013%225,773
Arnold Schneider 2017-12-31 Reduce -67.19%0.53%$13.95 - $17.9 $ 18.3013%91,468
Charles Brandes 2017-12-29 Reduce -82.32%0.36%Premium Member Access $16.85 $ 18.309%225,773
Mariko Gordon 2017-09-30 Reduce -8.91%0.2%$12.65 - $16.2 $ 18.3029%2,576,691
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Add 654.10%0.05%$12.65 - $16.2 $ 18.3029%2,383,222
Charles Brandes 2017-09-30 Reduce -16.67%0.05%$12.65 - $16.2 $ 18.3029%1,276,880
HOTCHKIS & WILEY 2017-09-30 Reduce -40.86%0.03%$12.65 - $16.2 $ 18.3029%786,865
Arnold Schneider 2017-09-30 Reduce -3.46%0.02%$12.65 - $16.2 $ 18.3029%278,770
Leucadia National 2017-09-30 Sold Out 0.01%$12.65 - $16.2 $ 18.3029%0
Mariko Gordon 2017-06-30 Reduce -3.22%0.07%$10.4 - $15.25 $ 18.3039%2,828,630
Charles Brandes 2017-06-30 Reduce -24.09%0.09%$10.4 - $15.25 $ 18.3039%1,532,394
HOTCHKIS & WILEY 2017-06-30 Reduce -0.57%$10.4 - $15.25 $ 18.3039%1,330,505
Arnold Schneider 2017-06-30 Add 126.44%0.4%$10.4 - $15.25 $ 18.3039%288,770
Leucadia National 2017-06-30 New Buy0.01%$10.4 - $15.25 $ 18.3039%12,204
Mariko Gordon 2017-03-31 Reduce -1.69%0.04%$11.15 - $13.7 $ 18.3053%2,922,828
Charles Brandes 2017-03-31 Add 5.05%0.02%$11.15 - $13.7 $ 18.3053%2,018,749
HOTCHKIS & WILEY 2017-03-31 Reduce -3.42%$11.15 - $13.7 $ 18.3053%1,338,095
Barrow, Hanley, Mewhinney & Strauss 2017-03-31 Add 3.50%$11.15 - $13.7 $ 18.3053%316,036
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NAS:TCMD, SZSE:300562, SZSE:300216, SZSE:300314, NAS:VRAY, MIL:ELN, SZSE:300206, HKSE:01789, XKRX:043150, SZSE:300318, NYSE:CRY, NAS:ARAY, NAS:CUTR, NAS:EXAC, ROCO:8406, LSE:CSRT, HKSE:01696, TSE:4549, OSTO:ARJO B, XKRX:099190 » details
Traded in other countries:IV3.Germany,
Headquarter Location:USA
Invacare Corp is a manufacturer and distributor of medical equipment used in non-acute care settings. The company sells its products to home medical equipment providers with retail and e-commerce channels, residential care operators, and distributors.

Invacare makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and nondelivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.

Ratios

vs
industry
vs
history
PB Ratio 1.42
IVC's PB Ratio is ranked higher than
81% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.85 vs. IVC: 1.42 )
Ranked among companies with meaningful PB Ratio only.
IVC' s PB Ratio Range Over the Past 10 Years
Min: 0.55  Med: 1.05 Max: 1.72
Current: 1.42
0.55
1.72
PS Ratio 0.63
IVC's PS Ratio is ranked higher than
89% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.19 vs. IVC: 0.63 )
Ranked among companies with meaningful PS Ratio only.
IVC' s PS Ratio Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.75
Current: 0.63
0.26
0.75
EV-to-EBIT -16.10
IVC's EV-to-EBIT is ranked lower than
99.99% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.04 vs. IVC: -16.10 )
Ranked among companies with meaningful EV-to-EBIT only.
IVC' s EV-to-EBIT Range Over the Past 10 Years
Min: -368.8  Med: -12.8 Max: 64.2
Current: -16.1
-368.8
64.2
EV-to-EBITDA -21.68
IVC's EV-to-EBITDA is ranked lower than
99.99% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 18.40 vs. IVC: -21.68 )
Ranked among companies with meaningful EV-to-EBITDA only.
IVC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1495  Med: 9 Max: 487
Current: -21.68
-1495
487
EV-to-Revenue 0.71
IVC's EV-to-Revenue is ranked higher than
92% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 3.64 vs. IVC: 0.71 )
Ranked among companies with meaningful EV-to-Revenue only.
IVC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.5 Max: 1
Current: 0.71
0.3
1
Current Ratio 2.28
IVC's Current Ratio is ranked lower than
57% of the 329 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. IVC: 2.28 )
Ranked among companies with meaningful Current Ratio only.
IVC' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 2.21 Max: 3.34
Current: 2.28
1.38
3.34
Quick Ratio 1.57
IVC's Quick Ratio is ranked lower than
60% of the 329 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. IVC: 1.57 )
Ranked among companies with meaningful Quick Ratio only.
IVC' s Quick Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.52 Max: 2.03
Current: 1.57
0.83
2.03
Days Inventory 73.24
IVC's Days Inventory is ranked higher than
78% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 141.33 vs. IVC: 73.24 )
Ranked among companies with meaningful Days Inventory only.
IVC' s Days Inventory Range Over the Past 10 Years
Min: 53.38  Med: 62.35 Max: 73.24
Current: 73.24
53.38
73.24
Days Sales Outstanding 47.44
IVC's Days Sales Outstanding is ranked higher than
83% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 66.85 vs. IVC: 47.44 )
Ranked among companies with meaningful Days Sales Outstanding only.
IVC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.53  Med: 51.7 Max: 64.57
Current: 47.44
40.53
64.57
Days Payable 47.41
IVC's Days Payable is ranked lower than
59% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 61.22 vs. IVC: 47.41 )
Ranked among companies with meaningful Days Payable only.
IVC' s Days Payable Range Over the Past 10 Years
Min: 34.47  Med: 46.5 Max: 55.1
Current: 47.41
34.47
55.1

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.27
IVC's Dividend Yield % is ranked lower than
93% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 1.24 vs. IVC: 0.27 )
Ranked among companies with meaningful Dividend Yield % only.
IVC' s Dividend Yield % Range Over the Past 10 Years
Min: 0.15  Med: 0.3 Max: 0.55
Current: 0.27
0.15
0.55
Forward Dividend Yield % 0.27
IVC's Forward Dividend Yield % is ranked lower than
95% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. IVC: 0.27 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.27
IVC's 5-Year Yield-on-Cost % is ranked lower than
91% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 1.54 vs. IVC: 0.27 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IVC' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15  Med: 0.3 Max: 0.55
Current: 0.27
0.15
0.55
3-Year Average Share Buyback Ratio -0.40
IVC's 3-Year Average Share Buyback Ratio is ranked higher than
77% of the 247 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. IVC: -0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
IVC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -8.4  Med: -0.7 Max: 0.4
Current: -0.4
-8.4
0.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.75
IVC's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
62% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 2.37 vs. IVC: 2.75 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
IVC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.33  Med: 1.13 Max: 7.51
Current: 2.75
0.33
7.51
Price-to-Median-PS-Value 1.49
IVC's Price-to-Median-PS-Value is ranked lower than
77% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. IVC: 1.49 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
IVC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.63  Med: 1.69 Max: 3.88
Current: 1.49
0.63
3.88
Earnings Yield (Greenblatt) % -6.21
IVC's Earnings Yield (Greenblatt) % is ranked lower than
69% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. IVC: -6.21 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
IVC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -25.6  Med: -1.7 Max: 11
Current: -6.21
-25.6
11
Forward Rate of Return (Yacktman) % -23.62
IVC's Forward Rate of Return (Yacktman) % is ranked lower than
96% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 6.87 vs. IVC: -23.62 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
IVC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -23.62  Med: 8.5 Max: 20.4
Current: -23.62
-23.62
20.4

More Statistics

Revenue (TTM) (Mil) $966.50
EPS (TTM) $ -2.35
Beta2.29
Short Percentage of Float37.16%
52-Week Range $10.20 - 19.05
Shares Outstanding (Mil)32.84

Piotroski F-Score Details

Piotroski F-Score: 33
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}